Colorectal and Lung Tumoroids are Now Available NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions NEW Blog Post - Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con

Colorectal and Lung Tumoroids are Now Available NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions NEW Blog Post - Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con

How are the cell counts and viabilities of BMMCs determined?

Cell counts and viability are determined using AOPI staining on a Nexcelom Cellometer.

Privacy Settings